Privia Health Group, Inc. reported $2.36B of revenue over the trailing twelve months, +24% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.36B (to Q2 2026). Net income: $28M, trailing twelve months to Q2 2026. Operating margin: 1.9%, trailing twelve months to Q2 2026. EPS: $0.21, trailing twelve months to Q2 2026.

PRVAPrivia Health Group, Inc.

Healthcare

$20.85-6.8% 1Y

$20.85

$19.1152 weeks$28.10

PRVA as reported

Privia Health Group, Inc. reported $2.36B of revenue over the trailing twelve months, +24% on the year before. 10 reported series are charted on this page, each one as filed.

$2.36B

Revenue, trailing twelve months · to Q2 2026 · +24% against the twelve months before

Net income: $28M
Net income · +90% year on year · trailing twelve months to Q2 2026
Operating margin: 1.9%
Operating margin · trailing twelve months to Q2 2026
EPS: $0.21
EPS · +91% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PRVA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.36B	+24%	Q2 2026
Net income	$28M	+90%	Q2 2026
EPS	$0.21	+91%	Q2 2026
Operating margin	1.9%	n/a	Q2 2026
Net margin	1.2%	n/a	Q2 2026
ROE	3.0%	n/a	Q2 2026
ROA	1.6%	n/a	Q2 2026
ROIC	−45%	n/a	Q4 2022 · 14 quarters behind
Free cash flow	$81M	n/a	Q4 2023 · 10 quarters behind
P/E	99.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.